An observational study in patients who received nivolumab preoperatively for stage 1 non-small cell lung cancer considered as high-risk of relapse
Not Applicable
- Conditions
- non small cell lung cancer
- Registration Number
- JPRN-jRCT1060190007
- Lead Sponsor
- Okada Morihito
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
1.Patients enrolled and received nivolumab therapy in the POTENTIAL study.
2.Subjects who were fully informed beforehand about their participation in this observational study and agreed to participate in the study in writing.
Exclusion Criteria
1.Patients who are limited, or predicted to be limited, for participation of this study by geographic or social factors during the study period.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method overall survival
- Secondary Outcome Measures
Name Time Method progression-free survival